110 related articles for article (PubMed ID: 23544584)
1. Construction of hyaluronic acid noisome as functional transdermal nanocarrier for tumor therapy.
Kong M; Park H; Feng C; Hou L; Cheng X; Chen X
Carbohydr Polym; 2013 Apr; 94(1):634-41. PubMed ID: 23544584
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid-containing ethosomes as a potential carrier for transdermal drug delivery.
Xie J; Ji Y; Xue W; Ma D; Hu Y
Colloids Surf B Biointerfaces; 2018 Dec; 172():323-329. PubMed ID: 30176512
[TBL] [Abstract][Full Text] [Related]
3. Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy.
Choi KY; Yoon HY; Kim JH; Bae SM; Park RW; Kang YM; Kim IS; Kwon IC; Choi K; Jeong SY; Kim K; Park JH
ACS Nano; 2011 Nov; 5(11):8591-9. PubMed ID: 21967065
[TBL] [Abstract][Full Text] [Related]
4. Novel Self-assembled, Gel-core Hyaluosomes for Non-invasive Management of Osteoarthritis: In-vitro Optimization, Ex-vivo and In-vivo Permeation.
El-Refaie WM; Elnaggar YS; El-Massik MA; Abdallah OY
Pharm Res; 2015 Sep; 32(9):2901-11. PubMed ID: 25777613
[TBL] [Abstract][Full Text] [Related]
5. pH sensitive polymeric complex of cisplatin with hyaluronic acid exhibits tumor-targeted delivery and improved in vivo antitumor effect.
Fan X; Zhao X; Qu X; Fang J
Int J Pharm; 2015 Dec; 496(2):644-53. PubMed ID: 26529576
[TBL] [Abstract][Full Text] [Related]
6. Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel.
Cho HJ; Yoon HY; Koo H; Ko SH; Shim JS; Lee JH; Kim K; Kwon IC; Kim DD
Biomaterials; 2011 Oct; 32(29):7181-90. PubMed ID: 21733572
[TBL] [Abstract][Full Text] [Related]
7. Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel.
Li J; Huo M; Wang J; Zhou J; Mohammad JM; Zhang Y; Zhu Q; Waddad AY; Zhang Q
Biomaterials; 2012 Mar; 33(7):2310-20. PubMed ID: 22166223
[TBL] [Abstract][Full Text] [Related]
8. Study on intralymphatic-targeted hyaluronic acid-modified nanoliposome: influence of formulation factors on the lymphatic targeting.
Tiantian Y; Wenji Z; Mingshuang S; Rui Y; Shuangshuang S; Yuling M; Jianhua Y; Xinggang Y; Shujun W; Weisan P
Int J Pharm; 2014 Aug; 471(1-2):245-57. PubMed ID: 24858386
[TBL] [Abstract][Full Text] [Related]
9. Nano-proniosomes enhancing the transdermal delivery of mefenamic acid.
Wen MM; Farid RM; Kassem AA
J Liposome Res; 2014 Dec; 24(4):280-9. PubMed ID: 24779560
[TBL] [Abstract][Full Text] [Related]
10. Bioreducible shell-cross-linked hyaluronic acid nanoparticles for tumor-targeted drug delivery.
Han HS; Thambi T; Choi KY; Son S; Ko H; Lee MC; Jo DG; Chae YS; Kang YM; Lee JY; Park JH
Biomacromolecules; 2015 Feb; 16(2):447-56. PubMed ID: 25565417
[TBL] [Abstract][Full Text] [Related]
11. Application of hyaluronic acid as carriers in drug delivery.
Huang G; Huang H
Drug Deliv; 2018 Nov; 25(1):766-772. PubMed ID: 29536778
[TBL] [Abstract][Full Text] [Related]
12. Enhanced transdermal lymphatic drug delivery of hyaluronic acid modified transfersomes for tumor metastasis therapy.
Kong M; Hou L; Wang J; Feng C; Liu Y; Cheng X; Chen X
Chem Commun (Camb); 2015 Jan; 51(8):1453-6. PubMed ID: 25493296
[TBL] [Abstract][Full Text] [Related]
13. Dermal targeting of
Wichayapreechar P; Anuchapreeda S; Phongpradist R; Rungseevijitprapa W; Ampasavate C
J Liposome Res; 2020 Jun; 30(2):197-207. PubMed ID: 31060402
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronan nanocapsules as a new vehicle for intracellular drug delivery.
Oyarzun-Ampuero FA; Rivera-RodrÃguez GR; Alonso MJ; Torres D
Eur J Pharm Sci; 2013 Jul; 49(4):483-90. PubMed ID: 23684914
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid functional amphipathic and redox-responsive polymer particles for the co-delivery of doxorubicin and cyclopamine to eradicate breast cancer cells and cancer stem cells.
Hu K; Zhou H; Liu Y; Liu Z; Liu J; Tang J; Li J; Zhang J; Sheng W; Zhao Y; Wu Y; Chen C
Nanoscale; 2015 May; 7(18):8607-18. PubMed ID: 25898852
[TBL] [Abstract][Full Text] [Related]
16. Development of novel diolein-niosomes for cutaneous delivery of tretinoin: influence of formulation and in vitro assessment.
Manca ML; Manconi M; Nacher A; Carbone C; Valenti D; Maccioni AM; Sinico C; Fadda AM
Int J Pharm; 2014 Dec; 477(1-2):176-86. PubMed ID: 25455770
[TBL] [Abstract][Full Text] [Related]
17. Stimuli-Responsive Polysaccharide Enveloped Liposome for Targeting and Penetrating Delivery of survivin-shRNA into Breast Tumor.
Chen H; Fan X; Zhao Y; Zhi D; Cui S; Zhang E; Lan H; Du J; Zhang Z; Zhang S; Zhen Y
ACS Appl Mater Interfaces; 2020 May; 12(19):22074-22087. PubMed ID: 32083833
[TBL] [Abstract][Full Text] [Related]
18. Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery.
Jiang T; Zhang Z; Zhang Y; Lv H; Zhou J; Li C; Hou L; Zhang Q
Biomaterials; 2012 Dec; 33(36):9246-58. PubMed ID: 23031530
[TBL] [Abstract][Full Text] [Related]
19. Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery.
Liu Y; Sun J; Cao W; Yang J; Lian H; Li X; Sun Y; Wang Y; Wang S; He Z
Int J Pharm; 2011 Dec; 421(1):160-9. PubMed ID: 21945183
[TBL] [Abstract][Full Text] [Related]
20. Improved stability and skin permeability of sodium hyaluronate-chitosan multilayered liposomes by Layer-by-Layer electrostatic deposition for quercetin delivery.
Jeon S; Yoo CY; Park SN
Colloids Surf B Biointerfaces; 2015 May; 129():7-14. PubMed ID: 25819360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
